Lilly Brings Full Value Of Cialis In-House With Purchase Of Partner ICOS
Executive Summary
Lilly will acquire its joint venture partner ICOS for approximately $2.1 bil. to gain the full rights to the erectile dysfunction drug Cialis (tadalafil), which the two companies have partnered on since 1998
You may also be interested in...
The Next Bristol/ImClone? “Standstill” Provisions Complicate Other Deals
Roche and Bristol-Myers Squibb have everyone wondering who will be the next company to buy out its biotech partner
The Next Bristol/ImClone? “Standstill” Provisions Complicate Other Deals
Roche and Bristol-Myers Squibb have everyone wondering who will be the next company to buy out its biotech partner
Erectile Dysfunction Class Labeling Excludes Causal Link To Vision Loss
FDA's class labeling for oral erectile dysfunction disorder drugs on the incidence of non-arteritic anterior ischemic optic neuropathy notes that it is unknown whether the drugs are connected to the adverse events